Finding reliable data to support clinical screening is a challenge

At a time when physicians and pharmacists are facing hundreds of medication-related decisions each day, the complexity of using EMRs and the rise of adverse drug events globally make it an ongoing challenge to deliver the best patient care. What’s more, a variety of factors about the patient must be taken into account before making medication decisions, or the consequences can be dire. We are here to help.

Medi-Span Clinical offers a variety of clinical screening modules
  • Dose Screening + Drug Orders
    • Provides information about a drug’s dose, frequency, and duration of therapy (Dose Screening), dosing at the ingredient level of a drug; and instructions for use—often referred to as sigs, the latin for “to write” (Drug Orders)*
    • Dose range screening for adult, pediatric, and neonatal patient populations
    • Patient inputs include patient age, weight, body surface area, renal function, medical condition, and dose type
    • Multiple types of screening can be performed including daily low/high/max, single dose max, frequency low/high/max, therapy duration low/high/max, and lifetime max

    * Drug Orders functionality is not available in all countries

  • Drug Allergy Screening
    • Provides data content about drug allergies and associated adverse reactions
    • Includes drugs and herbal/natural products
    • Facilitates screening by ingredient, allergen class, or drug product
    • Differentiates allergies by type; same drug, same class, or cross-sensitivity
    • Additionally, the API provides “common” concepts for allergens that facilitate creation of a clinician picklist that can be used to populate a patient’s allergy profile
  • Drug Disease Contraindications
    • Assists in the detection and reporting of conflicts related to the use of a medication in a patient with a given disease state or known genetic factors
    • Filter parameter available for Severity Level filtering; parameter ranges from Contraindicated to Informational levels
  • Drug Interaction Screening
    • Provides information about drug-drug, drug-food, and drug-alcohol interactions
    • Provides route and ingredient-specific interactions and allows for latency interactions
    • Includes attributes for severity, includes level of supporting documentation, management, and onset
    • Considers contextual factors such as age, gender, and dosage when providing information on interactions
  • Duplicate Therapy Screening
    • Provides data to support screening for potentially inappropriate therapeutic duplications. Includes codes identifying duplications involving ingredient, mechanism of action, or therapeutic indication, as well as a Duplication Allowance Indicator to specify a number of acceptable duplications before providing an alert
  • Pregnancy, Lactation, Age, and Gender Screening
    • Provides data to support screening for potential therapeutic conflicts between a drug and a patient based on available information about current medical condition, age, gender, pregnancy/lactation status, and known pharmacogenomic factors
    • The significance of the therapeutic conflict is quantified, allowing users to determine which screening alerts they wish to receive
  • Route Contraindications
    • Identifies routes of administration contraindicated or not recommended due to:
      • Safety concerns (e.g., Vincristine Sulfate via intrathecal route, otic solutions via ophthalmic route)
      • Drug formulation (e.g., extended release oral tablets via nasogastric tube)
  • US Controlled Substances
    • For the US only, displays a drugs’ Drug Enforcement Agency (DEA), State or Territory schedule status (when available)
    • For the US only, denotes if a National Drug Code (NDC) is required for an electronic prescription (if available)

Speak to an expert 

Please fill out the form and one of our experts will be in touch with you to discuss how Medi-Span can help your healthcare organization. 

Back To Top